Фото: Getty Images
First coronavirus pills approved in EU
–
–
The drug from the coronavirus Molnupiravir was developed by the American pharmaceutical giant MSD.
In the European Union, the Medicines Agency (EMA) has approved an emergency authorization for the use of the coronavirus drug Molnupiravir by the American pharmaceutical giant MSD. This was reported by the press service of the agency on Friday, November 19.
“The EMA Committee on Medicines (CHMP) has issued guidelines for the use of Lagevrio (also known as molnupiravir or MK 4482) for the treatment of COVID-19. The drug, which is not currently registered in the EU, can be used to treat adults who do not need additional oxygen and have an increased risk of developing a severe form of coronavirus, “the statement said.
The tablets should be added to treatment as soon as possible after the diagnosis of COVID-19 and within five days of the onset of symptoms. The medicine comes in the form of capsules, they must be taken twice a day for five days.
According to the manufacturer, the agent reduces the ability of the coronavirus to multiply in the cells of the body and slows down the further development of COVID-19.
In addition, the EMA has begun testing Paxlovid coronavirus pills from US pharmaceutical giant Pfizer – the drug reduces the likelihood of hospitalization or death by 89% in high-risk patients.
Recall that in eight regions of Ukraine discovered a new subtype of Delta strain… A new variant of the Delta strain was identified in Odessa, Lvov, Ternopil, Rivne, Ivano-Frankivsk, Volyn, Transcarpathian and Kherson regions.
Ministry of Health: The peak of the wave of coronavirus passed
News from Correspondent.net in Telegram. Subscribe to our channel https://t.me/korrespondentnet
– .
